Enwei Pharmaceutical Co., Ltd. has completed an IPO in the amount of CNY 522.692 million.
Security Name: A Shares
Security Type: Common Stock
Securities Offered: 17,540,000
PriceRange: CNY 29.8
Transaction Features: Sponsor Backed Offering
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.28 CNY | +1.83% | +1.75% | -2.74% |
05-14 | Enwei Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023 | CI |
04-21 | Enwei Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-2.74% | 377M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |